Morning Headlines 8/13/18
The Wall Street Journal posts another critical review of IBM Watson Health for oncology, saying that “the diagnosis is gloomy” for Watson’s ability to improve cancer treatments.
Cory Wiegert Named New CEO of CancerLinQ LLC
CancerLinQ, a non-profit data initiative of the American Society of Clinical Oncology, hires Corey Wiegert (IBM Watson Health) as CEO.
Lawmakers Decry Trump “Cronyism” at the VA
Legislators call for VA Secretary Robert Wilkie to provide unredacted copies of his correspondence with President Trump’s informal VA advisors following ProPublica’s piece on the “Mar-a-Lago Crowd” and its influence on VA politics and programs.
FDA allows marketing of first direct-to-consumer app for contraceptive use to prevent pregnancy
In an agency first, the FDA approves marketing of the Natural Cycles birth control app as part of its fast-track approval program for digital health devices.
I dont think anything will change until Dr Jayne and others take my approach of naming names, including how much…